Exploris Health AG has become a member of the Heart-Brain Alliance of leading healthcare players launched in 2021, including professional societies, patient organizations, health insurers and industry representatives. They are supported by scientific partners and sponsors from politics. The stated goal is to reduce the impact of cardiovascular disease on patients and society.
The expert alliance initiates concrete measures to raise general awareness, promote prevention, optimize patient pathways and advance research.
"We look forward to helping improve healthcare in Germany with our sophisticated AI technology in coordination with our very innovative alliance partners," said Peter Ruff, founder and CEO of Exploris Health AG.
Members include Novartis, Abbott, Novo Nordisk, Astra Zeneca, Sanofi-Aventis, Siemens Bundesverband Niedergelassener Kardiologen e.V., AOK Bayern and Niedersachsen and others.
About Exploris Health AG
Exploris Health AG is a pioneer in the provision of Artificial Intelligence (AI) with the aim of improving medicine. The innovative solutions focus on personalized medicine, high reliability and precision. We are thus transforming medicine towards greater safety and comfort for patients and physicians. The first product Cardio Explorer® has been approved in Europe and Switzerland, and further AI applications in the field of heart failure, among others, are under development.
On cardiovascular disease - the number one cause of death
Cardiovascular diseases are the most common cause of death worldwide. In Germany alone, more than 380,000 people die each year from cardiovascular diseases such as heart attacks and strokes. That is around one in three deaths in Germany.
In the future, even more people will be affected by these diseases. Cardiovascular diseases often lead to great personal suffering for those affected and their families. In addition, the diagnosis and treatment of these diseases place a heavy financial burden on the healthcare and social systems. A large proportion of the illnesses and deaths can be attributed to influenceable or preventable risk factors - up to 80% according to the World Heart Federation. This prevention potential must be leveraged.
